Please wait while we load the requested 8-K report or click the link below:
https://last10k.com/sec-filings/report/1086303/000121390023074978/ea183857-8k_heyubiologi.htm
May 2024
April 2024
November 2023
November 2023
November 2023
August 2023
August 2023
February 2023
Please wait while we load the requested 8-K report or click the link below:
https://last10k.com/sec-filings/report/1086303/000121390023074978/ea183857-8k_heyubiologi.htm
Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Heyu Biological Technology Corp.
Heyu Biological Technology Corp's Definitive Proxy Statement (Form DEF 14A) filed after their 2023 10-K Annual Report includes:
Financial Statements, Disclosures and Schedules
Inside this 8-K Corporate News
Material Contracts, Statements, Certifications & more
Heyu Biological Technology Corp provided additional information to their SEC Filing as exhibits
Ticker: HYBTEvents:
CIK: 1086303
Form Type: 8-K Corporate News
Accession Number: 0001213900-23-074978
Submitted to the SEC: Thu Sep 07 2023 4:10:39 PM EST
Accepted by the SEC: Thu Sep 07 2023
Period: Monday, September 4, 2023
Industry: Prepackaged Software